Verano Holdings (VRNO) Retained Earnings (2024 - 2026)
Verano Holdings (VRNO) reported Retained Earnings of -$1.1 billion for Q1 2026, down 35.19% quarter-over-quarter from -$783.6 million in Q4 2024.
Verano Holdings (VRNO) Retained Earnings (2024 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 2 years of Retained Earnings data on file, last reported at -$1.1 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 billion (changed N/A YoY), and the FY2024 annual result was -$783.6 million, changed N/A from the prior year.
- Retained Earnings declined to -$1.1 billion in Q1 2026 per VRNO's latest filing, from -$783.6 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$783.6 million in Q4 2024 and troughed at -$1.1 billion in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | -1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 Bn |
| Dec 31, 2024 | -783.61 Mn |